Potential anticancer drug. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells HT29 Cells HCT116 Cells Hep G2 Cells HL-60 Cells K562 Cells HeLa Cells KB Cells Cell Line Mitochondria

Organisms4

Oplopanax Mice, Nude Taxus Mice, Inbred BALB C

Diseases7

Neoplasms Breast Neoplasms Colonic Neoplasms Leukemia P388 Neoplasms, Experimental Lung Neoplasms Leukemia L1210

Chemicals and Drugs67

Antineoplastic Agents Antineoplastic Agents, Phytogenic Xanthones Plant Extracts Tubulin Modulators Enzyme Inhibitors Doxorubicin Antibiotics, Antineoplastic Cisplatin Drug Carriers Ellipticines Camptothecin P-Glycoprotein Etoposide Paclitaxel DNA Topoisomerases, Type II Prodrugs Daunorubicin Topoisomerase I Inhibitors Platinum Nanocapsules Caspases Organoplatinum Compounds Mitomycin Fluorouracil Mitoxantrone Drugs, Investigational Antimetabolites, Antineoplastic Multidrug Resistance-Associated Proteins Intercalating Agents DNA Adducts Caspase 3 Proto-Oncogene Proteins c-bcl-2 Topoisomerase Inhibitors Adjuvants, Pharmaceutic ATP-Binding Cassette Transporters Topoisomerase II Inhibitors Neoplasm Proteins Coordination Complexes DNA Tumor Suppressor Protein p53 DNA Topoisomerases, Type I Antineoplastic Agents, Alkylating Anticarcinogenic Agents Razoxane Liposomes Vinblastine Teniposide Bleomycin RNA, Small Interfering Vinca Alkaloids Histone Deacetylase Inhibitors Triazines Pyrazines Topotecan Triterpenes Depsipeptides Chlorambucil Reactive Oxygen Species Boronic Acids Benzoquinones Polyethylene Glycols Angiogenesis Inhibitors Amsacrine Rhodamine 123 RNA, Messenger Nimustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment23

Drug Screening Assays, Antitumor Drug Design Inhibitory Concentration 50 Xenograft Model Antitumor Assays Models, Molecular Drug Delivery Systems Drug Carriers Drug Discovery Nanocapsules Drug Evaluation, Preclinical Molecular Targeted Therapy Neoplasms, Experimental Neoplasm Transplantation Blotting, Western Clinical Trials, Phase I as Topic Flow Cytometry Transplantation, Heterologous Antineoplastic Combined Chemotherapy Protocols Models, Biological Phytotherapy Transfection Clinical Trials as Topic Drug Approval

Phenomena and Processes27

Molecular Structure Apoptosis DNA Cleavage Cell Proliferation Inhibitory Concentration 50 Cell Survival Structure-Activity Relationship Cell Cycle Dose-Response Relationship, Drug Signal Transduction Cell Division Drug Resistance, Neoplasm Drug Resistance, Multiple Drug Synergism DNA Damage Gene Expression Regulation, Neoplastic DNA Adducts Genes, MDR Drug Resistance Cell Death Particle Size Cell Cycle Checkpoints Down-Regulation Transfection DNA Repair Time Factors G-Quadruplexes

Disciplines and Occupations4

Drug Design Nanomedicine Drug Discovery Pharmacogenetics

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture6

Nanomedicine Nanoparticles Nanocapsules Liposomes Nanostructures Polyethylene Glycols

Health Care2

Clinical Trials, Phase I as Topic Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Health Care

Antineoplastic Agents Drug Screening Assays, Antitumor Cell Line, Tumor Oplopanax Molecular Structure Antineoplastic Agents, Phytogenic Neoplasms Apoptosis DNA Cleavage Cell Proliferation Xanthones Drug Design Plant Extracts Inhibitory Concentration 50 Tubulin Modulators Cell Survival Xenograft Model Antitumor Assays Mice, Nude Tumor Cells, Cultured Structure-Activity Relationship Enzyme Inhibitors Cell Cycle Dose-Response Relationship, Drug Breast Neoplasms Doxorubicin Signal Transduction Models, Molecular Cell Division Drug Resistance, Neoplasm Antibiotics, Antineoplastic Drug Delivery Systems Cisplatin Drug Carriers Ellipticines Camptothecin Drug Resistance, Multiple P-Glycoprotein Etoposide Paclitaxel Drug Synergism DNA Topoisomerases, Type II Prodrugs Daunorubicin Topoisomerase I Inhibitors Nanomedicine Nanoparticles DNA Damage Platinum Drug Discovery Nanocapsules Drug Evaluation, Preclinical Gene Expression Regulation, Neoplastic Colonic Neoplasms Caspases Organoplatinum Compounds Mitomycin Fluorouracil Mitoxantrone Drugs, Investigational Antimetabolites, Antineoplastic Multidrug Resistance-Associated Proteins Molecular Targeted Therapy Intercalating Agents DNA Adducts Caspase 3 Proto-Oncogene Proteins c-bcl-2 Leukemia P388 MCF-7 Cells Genes, MDR HT29 Cells Topoisomerase Inhibitors Neoplasms, Experimental Adjuvants, Pharmaceutic ATP-Binding Cassette Transporters Topoisomerase II Inhibitors HCT116 Cells Drug Resistance Neoplasm Proteins Coordination Complexes Neoplasm Transplantation Lung Neoplasms DNA Cell Death Taxus Tumor Suppressor Protein p53 DNA Topoisomerases, Type I Antineoplastic Agents, Alkylating Anticarcinogenic Agents Blotting, Western Clinical Trials, Phase I as Topic Flow Cytometry Razoxane Particle Size Liposomes Cell Cycle Checkpoints Hep G2 Cells Vinblastine HL-60 Cells Transplantation, Heterologous K562 Cells

No FAQ available that match "potential anticancer drug"